Skip to content
DeepViews

Stratasys Inc (ISRAEL) (SSYS) — Analysis Summary

Stratasys Inc (ISRAEL) (SSYS) has a market cap of $698.94M with year-over-year revenue growth of -3.7%. Net margin stands at -18.9%. The stock trades at a P/E ratio of -6.7.

Key Takeaways

  • Revenue changed -3.7% year-over-year
  • Net margin of -18.9%
  • P/E ratio of -6.7

Compared with its sector, SSYS posted revenue growth of -3.7% and trades at a P/E of -6.7.

[XNAS]

Stratasys Inc (ISRAEL) (SSYS)

$7.74

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$698.94M
Enterprise Value
$604.42M
P/E Ratio
-6.7
Div Yield
0.00%
EV/EBITDA
-20.6
Company Profile
About
About Stratasys Inc (ISRAEL)

Stratasys Ltd offers polymer-based 3D printing solutions for designers, engineers, manufacturers, dental and medical professionals, and others. Its 3D printing systems utilize the firm's patented extrusion-based FDM, inkjet-based PolyJet, powder-bed-based SAF, photopolymer-based P3, and Neo stereolithography technologies to enable the production of prototypes, tools, and manufactured goods directly from 3D CAD files or other 3D content. The company's solutions portfolio comprises 3D printing systems, consumables, software, paid parts, and professional services, allowing end-users to effectively print 3D models, tools, and parts. Geographically, it generates maximum revenue from the United States, followed by Europe, Middle East and Africa, Asia-Pacific, and other regions.

Employees

1,757

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
44
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$842.90M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$94.53M

Cash Flow

Operating Cash Flow$15.14M
Free Cash Flow$-6.97M
FCF Margin-1.26%
P/FCF Ratio-100.29
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.